Search

everythinglearnresearchcommunity

for

Search:↓

Masculinizing hormone therapy increases the risk of hair loss in transgender and gender-diverse patients.

Androgens may worsen COVID-19 severity in men.

Finasteride changes androgen receptor location in rat epididymis without altering tissue structure.

Hormone treatment before hypospadias surgery can increase penis size and reduce surgery complications.

Hesperidin helps protect against testicular damage caused by finasteride.

Finasteride can cause itching, burning, and other side effects that may not go away after treatment.

Finasteride, a hair loss drug, can cause long-lasting sexual side effects like low libido and erectile dysfunction.

A man had a rare stroke possibly due to taking finasteride, which might have increased his hormone levels causing a blood clot. His memory loss didn't fully recover even after stopping the medication.

Starting 5-alpha reductase inhibitors does not significantly increase the risk of rhabdomyolysis in older men, but is linked to a higher risk of muscle conditions.

Thorough evaluation is crucial for postmenopausal women with virilization to detect rare ovarian tumors.

Finasteride, dutasteride, and silodosin have the highest risk for causing sexual dysfunction.

COVID-19 might affect male fertility, but more research is needed to understand the full impact.

A rare pituitary tumor in an 18-year-old male caused hormonal issues and vision loss, requiring surgery and further treatment.

5-alpha reductase deficiency leads to male sexual development issues and treatments like finasteride help with prostate enlargement and hair loss.

Long use of finasteride and dutasteride can cause long-term erection problems.

A postmenopausal woman had high testosterone from her right adrenal gland, leading to recommended surgery.

Immunotherapy for cancer caused a patient to develop a condition affecting hormone production, requiring ongoing hormone replacement therapy.

Knowing about finasteride's sexual side effects increases reported dysfunction.

Postmenopausal women with excess male hormones may have ovarian tumors, and surgery usually cures them.

Post-Finasteride Syndrome causes lasting sexual, mood, and metabolic issues, needing personalized treatment and better informed consent.

Finasteride helps improve treatment for benign prostatic hyperplasia.

A small BOTOX dose improved sperm production and movement in older mice.

Long-term antiandrogen use may increase aggressive prostate cancer risk.

Testosterone replacement therapy, especially intramuscular, raises PSA levels, but no overall link between PSA and testosterone was found except in non-BPH patients.

5-α-reductase inhibitors reduce prostate cancer risk but may cause sexual dysfunction and don't affect high-grade tumor or death rates.

A man's breast enlargement from low-dose finasteride for hair loss didn't go away, even with treatment, and might be more common than reported.

New treatments for long-lasting erections improve outcomes but must be timely to avoid lasting damage.

Phosphodiesterase inhibitors like tadalafil can reduce cell growth in BPH caused by CD8+ T cells in low androgen conditions.